AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2016
May 9, 2016
31949_dirs_2016-05-09_6075b7c4-c5a0-4767-ae4c-738d63fc652e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-05-05
Reporting Person: Langloss Timothy J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-05 | Ordinary Shares | M | 3340 | $3.59 | Acquired | 35548 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-05 | Warrant | $3.59 | M | 3340 | Disposed | 2016-05-08 | Ordinary Shares (3340) | Direct |
Footnotes
F1: Consists of 3,340 ordinary shares acquired pursuant to the transaction reported on this Form 4 and 32,208 ordinary shares already owned.
F2: Exercisable at any time through May 8, 2016.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3